Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, February 20, 2019

Depression after ischemic stroke associated with low adherence to secondary prevention

Depression wouldn't be a problem if you solved the primary issue, 100% recovery. All these secondary issues go away when that is solved. Don't you understand? 

Depression after ischemic stroke associated with low adherence to secondary prevention

February 18, 2019
Patients who survived an ischemic stroke and were diagnosed with depression were less likely to adhere to key secondary prevention drugs compared with those without depression, according to data presented at the International Stroke Conference.
William P. Neil, MD, vascular neurologist at Southern California Permanente Medical Group in San Diego, and colleagues analyzed data from 9,933 patients with ischemic stroke from a multicenter database with information obtained from pharmacy records and electronic medical records.
Patients presented to one of 11 centers in California and had filled at least two medications for stroke prevention from 2007 to June 2015. Researchers calculated adherence for hypoglycemic, antihypertensive and lipid-lowering medications.
Of the patients in this study, 2,019 were diagnosed with depression after the index stroke. According to continuous medication gap methodology, adherence was 0.22 in patients without depression (standard deviation ± 0.29) and 0.28 in those with depression (standard deviation ± 0.32; P < .0001).
“Poor medication adherence among depressed stroke patients may be an important contributor to their relatively poorer clinical outcomes,” Neil and colleagues wrote. – by Darlene Dobkowski
Reference:
Neil WP, et al. Session MP15: Community/Risk Factors Moderated Poster Tour II. Presented at: International Stroke Conference; Feb. 6-8, 2019; Honolulu.
Disclosures: The authors report no relevant financial disclosures.

Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)